An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells
出版年份 2020 全文链接
标题
An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells
作者
关键词
Hepatocellular carcinoma (HCC), Aptamer, Cancer stem-like cells, CD133, Therapeutic targeting
出版物
CANCER LETTERS
Volume 501, Issue -, Pages 124-132
出版商
Elsevier BV
发表日期
2020-12-20
DOI
10.1016/j.canlet.2020.12.022
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model
- (2019) Sarah Walker et al. PLoS One
- An exploration of aptamer internalization mechanisms and their applications in drug delivery
- (2019) Lin-Yan Wan et al. Expert Opinion on Drug Delivery
- New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulation
- (2019) Marjan Aghajani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Role of the Extracellular Matrix in Cancer Stemness
- (2019) Sameera Nallanthighal et al. Frontiers in Cell and Developmental Biology
- Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers
- (2018) Gang Zhou et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
- (2018) Lan Thi Hanh Phi et al. Stem Cells International
- Incomplete radiofrequency ablation promotes the development of CD133+ cancer stem cells in hepatocellular carcinoma cell line HepG2 via inducing SOX9 expression
- (2018) Chun-Wang Yuan et al. Hepatobiliary & Pancreatic Diseases International
- CD133 as a regulator of cancer metastasis through the cancer stem cells
- (2018) Geou-Yarh Liou INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Deep Tumor-Penetrated Nanocages Improve Accessibility to Cancer Stem Cells for Photothermal-Chemotherapy of Breast Cancer Metastasis
- (2018) Tao Tan et al. Advanced Science
- Potential mechanisms of CD133 in cancer stem cells
- (2017) Jae-Woo Jang et al. LIFE SCIENCES
- Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
- (2017) Dongxi Xiang et al. Theranostics
- CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation
- (2016) Sha-sha Wang et al. Oncotarget
- Targeting Cancer Stem Cells as a Therapeutic Approach in Liver Cancer
- (2015) Gang Zhou et al. CURRENT GENE THERAPY
- Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma
- (2015) Cheolhee Won et al. HEPATOLOGY
- Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy
- (2015) C. K. Domigan et al. JOURNAL OF CELL SCIENCE
- Advanced research on vasculogenic mimicry in cancer
- (2015) Lili Qiao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice
- (2015) R Tolba et al. LABORATORY ANIMALS
- Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors
- (2015) Dongxi Xiang et al. Theranostics
- CD133-Targeted Niche-Dependent Therapy in Cancer
- (2014) Anthony B. Mak et al. AMERICAN JOURNAL OF PATHOLOGY
- Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells
- (2014) Aiping Tian et al. CANCER LETTERS
- Enhancement of the Tumor Penetration of Monoclonal Antibody by Fusion of a Neuropilin-Targeting Peptide Improves the Antitumor Efficacy
- (2014) T.-H. Shin et al. MOLECULAR CANCER THERAPEUTICS
- Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment
- (2013) Yu-jiao Song et al. CANCER LETTERS
- Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro
- (2013) George S. Wilson et al. CANCER LETTERS
- CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
- (2013) Rosa Nadal et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy of Using Cancer Stem Cell Markers in Isolating and Characterizing Liver Cancer Stem Cells
- (2013) George S. Wilson et al. STEM CELLS AND DEVELOPMENT
- Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
- (2012) Shiwu Wu et al. BMC CANCER
- RNA aptamers targeting cancer stem cell marker CD133
- (2012) Sarah Shigdar et al. CANCER LETTERS
- CD133+ Melanoma Subpopulations Contribute to Perivascular Niche Morphogenesis and Tumorigenicity through Vasculogenic Mimicry
- (2012) C.-Y. Lai et al. CANCER RESEARCH
- CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer
- (2012) T J Liu et al. ONCOGENE
- CD133+ Glioblastoma Stem-Like Cells Induce Vascular Mimicry in Vivo
- (2011) Ming-Tsang Chiao et al. CURRENT NEUROVASCULAR RESEARCH
- CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling
- (2011) Kwan Ho Tang et al. HEPATOLOGY
- CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
- (2008) L M Smith et al. BRITISH JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started